Stockreport

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

Zenas BioPharma, Inc.  (ZBIO) 
PDF WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being [Read more]